HealthcareServices

Polymerase Chain Reaction Molecular Diagnostics Market Trends and Insights: Global Forecast to 2030

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the polymerase chain reaction molecular diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Polymerase Chain Reaction Molecular Diagnostics Market’s size between 2026 and 2030?

The polymerase chain reaction molecular diagnostics market has shown robust growth in its size during recent years. Projections indicate it will expand from $9.75 billion in 2025 to $10.59 billion in 2026, with a compound annual growth rate (CAGR) of 8.7%. Its growth during the historical period stems from factors like the expansion of hospital-based molecular diagnostics, the increasing prevalence of infectious diseases, the availability of standardized pcr diagnostic kits, the growth of centralized diagnostic laboratories, and regulatory approvals for molecular tests.

The market for polymerase chain reaction molecular diagnostics is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $14.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. The predicted growth during this period stems from several factors, including the rising acceptance of point-of-care molecular diagnostics, increased funding for personalized medicine, the broadening of genomic testing initiatives, a greater need for decentralized diagnostics, and the enhanced incorporation of digital health platforms. Key trends expected within the forecast period involve a greater application of pcr in detecting infectious diseases, an escalating requirement for high-sensitivity molecular diagnostics, the broadening scope of pcr-based oncology examinations, the increasing incorporation of automated diagnostic systems, and a heightened emphasis on tests with swift results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp

Which Drivers Are Shaping Strategic Decisions In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market is anticipated to expand due to the increasing prevalence of infectious diseases. These illnesses are caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. The rise in infectious disease cases is attributed to the emergence of antibiotic-resistant pathogens, which are more challenging to treat and control, leading to prolonged sickness, increased healthcare expenses, and greater public health risks. Polymerase chain reaction (PCR) molecular diagnostics enhance the management of infectious diseases by offering rapid and accurate detection of pathogens at the genetic level, thus facilitating early diagnosis and targeted treatment. This improves healthcare outcomes by enabling timely interventions, reducing infection transmission, and optimizing patient care. For instance, the Centers for Disease Control and Prevention, a US-based government agency, indicated in April 2025 that 2,214 new cases of acute hepatitis B were reported in 2023, with an additional 1,769 hepatitis B-related deaths reported during the same year. Consequently, the rising prevalence of infectious diseases is a key factor driving the growth of the polymerase chain reaction molecular diagnostics market.

What Segment Categories Are Covered In The Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market covered in this report is segmented –

1) By Product Type: Instrument, Reagents And Consumables, Software

2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples

4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

Which Trends Are Influencing The Development Of The Polymerase Chain Reaction Molecular Diagnostics Market?

Leading firms within the polymerase chain reaction molecular diagnostics market are prioritizing the creation of advanced technological solutions, including benchtop instruments, to improve both the effectiveness and availability of testing. Benchtop instruments are defined as compact, laboratory-quality devices designed to be small enough for placement on a workbench or table, serving purposes in scientific, medical, or industrial testing and analysis. An example is QIAGEN N.V., a biotechnology company based in Germany, which introduced the QIAcuityDx Digital PCR System in September 2024, intended for clinical oncology testing. This system boasts fully automated, hands-off processing, consolidating partitioning, thermocycling, and imaging functions into one device. It provides absolute quantification of deoxyribonucleic acid and ribonucleic acid, yielding results in approximately two hours with very little manual intervention. Furthermore, the system accommodates up to five detection channels for multiplexing and supports continuous nanoplate loading. It provides both validated and customizable research modes, thereby offering versatility for various clinical and laboratory requirements.

Which Major Firms Are Strengthening Their Position In The Polymerase Chain Reaction Molecular Diagnostics Market?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., bioMereieux SA, Sysmex Corporation, Bio Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation, QIAGEN N.V., Cepheid Inc., Meridian Bioscience Inc., LGC Biosearch Technologies, Analytik Jena AG, Promega Corporation, BGI Genomics Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-molecular-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Polymerase Chain Reaction Molecular Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction Molecular Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Polymerase Chain Reaction Pcr Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-technologies-global-market-report

Dna Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795